Abstract We describe a typical case of a patient with remitting seronegative symmetrical synovitis and pitting edema (RS 3 PE) syndrome. He underwent a successful clinical course monitored by serologic variables and radiographic methods. Serum levels of interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 and serum amyloid A were remarkably elevated. Accumulation of inflammatory cells into the multiple joints was found by gallium-67 scintigraphy. Multiple and symmetrical tenosynovitis with hypervascularity in the presence of subcutaneous edema of the hands and feet were determined by magnetic resonance imaging (MRI) and ultrasonography. These serologic and radiographic abnormalities immediately improved after treatment with a low-dose steroid. Our present case supports a previous observation that synovial tissue is a major inflammatory source of RS 3 PE syndrome. IL-6 (and VEGF), probably produced from the synovial tissues, are considered to be essential factors in the development of RS 3 PE syndrome.
Keywords Remitting seronegative symmetrical synovitis with pitting edema (RS 3 PE) syndrome Á VEGF Á IL-6 Á Ga-67 scintigraphy Á MRI Á Ultrasonography Based on this case report, we suggest that the synovial tissues rich in humoral factors of IL-6, VEGF and matrix metalloproteinase-3 (MMP-3) are principal in the development of RS 3 PE syndrome.
Case report
A 59-year-old Japanese woman was admitted to our hospital because of polyarthralgia, edema of the dorsum of the bilateral hands and feet, and high fever on 23 August 2008. A physical examination showed remarkable symmetrical pitting edema of the dorsum of the hands and feet, and tenderness and warmth of joints of the bilateral shoulders, elbows, wrists and knees. Biochemical and serological data are shown in Table 1 . The blood count showed anemia. Creactive protein (CRP) and erythrocyte sedimentation rate (ESR) were increased. RF and anti-cyclic citrullinated peptide antibodies (anti-CCP Ab) were negative. The serum levels of interleukin-6 (IL-6), VEGF, MMP-3 and serum amyloid A (SAA) were markedly elevated. Bone erosion was not found by plain radiography. Ga-67 scintigraphy ( Fig. 1a) showed symmetrically multiple increased uptakes in the joints of the extremities. Dynamic MRI (Fig. 1b) detected synovitis of the wrists, metacarpophalangeal joints and proximal interphalangeal joints, tenovitis of extensor and flexor tendons, and diffuse subcutaneous edema in the bilateral hands. USG of the hands and feet (Fig. 1c ) also detected synovitis, tenosynovitis and subcutaneous edema of the dorsum.
The patient was diagnosed with RS 3 PE syndrome fulfilling the following criteria [2]: (1) bilateral pitting edema of the hands, (2) sudden onset of polyarthritis, (3) age [50 years, (4) seronegativity for RF. On 29 August 2009, treatment with oral prednisolone 15 mg daily was initiated. After the initiation of treatment, symptoms including fever, edema of the extremities and arthralgia promptly improved. Serologic variables were remarkably improved beginning 2 weeks after treatment (Table 2) . Tenosynovitis and subcutaneous edema in MRI and USG had almost disappeared at 1 month after the initiation of treatment, although a slight elevation of MMP-3 and SAA continued. We succeeded in tapering the dose of prednisolone without any recurrence.
Discussion
We previously reported synovial hypervascularity and subcutaneous edema in dynamic MRI with a remarkable increment of serum VEGF in patients with RS 3 PE syndrome [3] . After treatment, MRI abnormalities and high serum VEGF rapidly decreased [3]. We had discussed that both synovial hypervascularity and increment of vascular permeability may be facilitated by VEGF [3] . We have investigated this hypothesis more intensely in the present case by serologic variables and radiographic methods. These abnormalities have been reported previously [3-9]; however, this is the first report of a patient showing recovery from all these parameters at once after treatment. In vitro studies have revealed that IL-6 induces the production of VEGF [10] , MMP-3 [11] and SAA [12] . Since IL-6 concentration in synovial fluid of RS 3 PE syndrome is much higher than in serum [9] , IL-6, probably produced from the synovial tissues, may facilitate the pathologic status of RS 3 PE syndrome via VEGF and MMP-3.
Ga-67 scintigraphy allows the detection of the distribution of systemic synovitis, whereas MRI and USG are useful to show the local inflammatory process precisely. As expected, intense accumulation of synovial inflammatory cells with hypervascularity in the presence of subcutaneous edema and tenosynovitis was determined in our case, which may have been driven by IL-6, VEGF, MMP-3 and was clearly improved by traditional low-dose steroid. The findings in our present case support a previous observation that synovial tissues are a major inflammatory source of RS 3 PE syndrome. Both serologic and radiographic methods are quite beneficial in monitoring the disease activity of RS 3 PE syndrome. Normal concentrations of serum MMP-3 and SAA are 17.3-59.7 ng/ ml and \8 lg/ml, respectively Fig. 1 Ga-67 scintigraphy (a) showed symmetrically multiple increased uptakes in the joints of the extremities. Dynamic MRI (b) detected synovitis of the wrists, metacarpophalangeal joints and proximal interphalangeal joints, and tenovitis of the extensor and flexor tendons in the bilateral hands. USG of the hands and feet (c) also detected synovitis and subcutaneous edema of the dorsum
